Ginger Gregory compensation by year
BIOGEN Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $659,360 |
| Bonus | $0 |
| Stock awards | $3,489,675 |
| Option awards | $0 |
| Non-equity incentive | $827,526 |
| Pension and deferred compensation | $155 |
| All other | $103,542 |
| Total | $5,080,258 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 28, 2023, accession 0001193125-23-127639, and prior-year filings. Open the filing on EDGAR.
How this page was built: the BIOGEN INC. filed document, accession 0001193125-23-127639. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.
Insider transactions since the last proxy
36 Form 4 lines since the FY2022 proxy (filed April 28, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-02-13 | Grant or award derivative | — | 8,025 | $0.00 | 8,025 |
| 2026-02-06 | Tax withholding | — | 791 | $201.18 | 18,608.77 |
| 2026-02-06 | Exercise or conversion | — | 1,635 | $0.00 | 19,399.77 |
| 2026-02-06 | Tax withholding | — | 1,132 | $201.18 | 22,358.77 |
| 2026-02-06 | Exercise or conversion derivative | — | 1,635 | $0.00 | 0 |
| 2026-02-06 | Exercise or conversion derivative | — | 3,746 | $0.00 | 7,494 |
| 2026-02-06 | Exercise or conversion | — | 3,746 | $0.00 | 23,490.77 |
| 2026-02-06 | Exercise or conversion | — | 1,802 | $0.00 | 20,410.77 |
The 8 most recent of 36 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
BIOGEN’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Christopher Viehbacher | President and Chief Executive Officer | $30,488,593 |
| Michel Vounatsos | Former Chief Executive Officer | $26,625,221 |
| Michael McDonnell | Executive Vice President and Chief Financial Officer | $7,209,834 |
| Susan Alexander | Executive Vice President, Chief Legal Officer and Secretary | $6,790,152 |
| Chirfi Guindo | Former Executive Vice President, Global Product Strategy and Commercialization | $5,382,348 |
| Ginger Gregory · this page | Executive Vice President, Chief Human Resources Officer | $5,080,258 |
| Nicole Murphy | Executive Vice President, Head of Pharmaceutical Operations and Technology | $4,929,712 |
The full BIOGEN compensation record
free company briefThis page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BIOGEN proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.